{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T08:36:47Z","timestamp":1789202207629,"version":"build-2803163510"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["20FC1030"],"award-info":[{"award-number":["20FC1030"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.jneuroim.2023.578205","type":"journal-article","created":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T20:51:43Z","timestamp":1695243103000},"page":"578205","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Serum cytokine profiles in myasthenia gravis with anti-muscle-specific kinase antibodies"],"prefix":"10.1016","volume":"384","author":[{"given":"Manato","family":"Yasuda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiyuki","family":"Uzawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Ozawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Onishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Akamine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Kuwabara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jneuroim.2023.578205_bb0005","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1084\/jem.186.3.385","article-title":"Interferon gamma (IFN-gamma) is necessary for the genesis of acetylcholine receptor-induced clinical experimental autoimmune myasthenia gravis in mice","volume":"186","author":"Balasa","year":"1997","journal-title":"J. Exp. Med."},{"issue":"4\u20135","key":"10.1016\/j.jneuroim.2023.578205_bb0010","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S1359-6101(02)00025-4","article-title":"The role of interleukin-10 in autoimmune disease: systemic lupus erythematosus (SLE) and multiple sclerosis (MS)","volume":"13","author":"Beebe","year":"2002","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.jneuroim.2023.578205_bb0015","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jaut.2014.01.003","article-title":"Diagnostic and clinical classification of autoimmune myasthenia gravis","volume":"48\u201349","author":"Berrih-Aknin","year":"2014","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jneuroim.2023.578205_bb0020","doi-asserted-by":"crossref","first-page":"576752","DOI":"10.3389\/fimmu.2020.576752","article-title":"Interferon-\u03b3\/Interleukin-27 Axis induces programmed death ligand 1 expression in monocyte-derived dendritic cells and restores immune tolerance in central nervous system autoimmunity","volume":"11","author":"Casella","year":"2020","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.jneuroim.2023.578205_bb0025","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/ni1084","article-title":"Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice","volume":"5","author":"Dillon","year":"2004","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.jneuroim.2023.578205_bib187","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1600-065X.2009.00782.x","article-title":"Molecular mechanism and function of CD40\/CD40L engagement in the immune system","volume":"229","author":"Elgueta","year":"2009","journal-title":"Immunol. Rev."},{"issue":"6","key":"10.1016\/j.jneuroim.2023.578205_bb0030","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.2337\/db08-1113","article-title":"Inhibition of Th17 cells regulates autoimmune diabetes in NOD mice","volume":"58","author":"Emamaullee","year":"2009","journal-title":"Diabetes."},{"issue":"13","key":"10.1016\/j.jneuroim.2023.578205_bb0035","doi-asserted-by":"crossref","first-page":"7305","DOI":"10.1073\/pnas.1917834117","article-title":"Evidence for a pathogenic role of extrafollicular, IL-10-producing CCR6(+)B helper T cells in systemic lupus erythematosus","volume":"117","author":"Facciotti","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"26","key":"10.1016\/j.jneuroim.2023.578205_bb0040","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1056\/NEJMra1602678","article-title":"Myasthenia gravis","volume":"375","author":"Gilhus","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.jneuroim.2023.578205_bb0045","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jaut.2006.02.002","article-title":"Elevated levels of soluble CD40 ligand (sCD40L) in serum of patients with systemic autoimmune diseases","volume":"26","author":"Goules","year":"2006","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jneuroim.2023.578205_bb0050","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1600-065X.1996.tb00921.x","article-title":"The role of CD40 ligand in costimulation and T-cell activation","volume":"153","author":"Grewal","year":"1996","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jneuroim.2023.578205_bb0055","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1146\/annurev.immunol.16.1.111","article-title":"CD40 and CD154 in cell-mediated immunity","volume":"16","author":"Grewal","year":"1998","journal-title":"Annu. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.jneuroim.2023.578205_bb0060","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1212\/WNL.55.1.16","article-title":"Myasthenia gravis: recommendations for clinical research standards. Task force of the medical scientific advisory Board of the Myasthenia Gravis Foundation of America","volume":"55","author":"Jaretzki","year":"2000","journal-title":"Neurology."},{"issue":"7","key":"10.1016\/j.jneuroim.2023.578205_bb0065","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.4049\/jimmunol.160.7.3555","article-title":"IgE versus IgG4 production can be differentially regulated by IL-10","volume":"160","author":"Jeannin","year":"1998","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.jneuroim.2023.578205_bb0070","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1084\/jem.20061738","article-title":"IL-25 regulates Th17 function in autoimmune inflammation","volume":"204","author":"Kleinschek","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2023.578205_bb0075","doi-asserted-by":"crossref","first-page":"102337","DOI":"10.1016\/j.jaut.2019.102337","article-title":"Risk factors associated with myasthenia gravis in thymoma patients: the potential role of thymic germinal centers","volume":"106","author":"Lefeuvre","year":"2020","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jneuroim.2023.578205_bb0080","doi-asserted-by":"crossref","first-page":"108492","DOI":"10.1016\/j.clim.2020.108492","article-title":"Circulating Th1\/17 cells serve as a biomarker of disease severity and a target for early intervention in AChR-MG patients","volume":"218","author":"Ma","year":"2020","journal-title":"Clin. Immunol."},{"issue":"4","key":"10.1016\/j.jneuroim.2023.578205_bb0085","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/ana.20061","article-title":"Detection and characterization of MuSK antibodies in seronegative myasthenia gravis","volume":"55","author":"McConville","year":"2004","journal-title":"Ann. Neurol."},{"issue":"5","key":"10.1016\/j.jneuroim.2023.578205_bb0090","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1474-4422(09)70063-8","article-title":"Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity","volume":"8","author":"Meriggioli","year":"2009","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.jneuroim.2023.578205_bb0095","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s12016-015-8514-7","article-title":"Regulator versus effector paradigm: Interleukin-10 as indicator of the switching response","volume":"50","author":"Mingomataj","year":"2016","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"23","key":"10.1016\/j.jneuroim.2023.578205_bb0100","doi-asserted-by":"crossref","first-page":"5856","DOI":"10.3390\/ijms20235856","article-title":"IL-33\/IL-31 Axis in immune-mediated and allergic diseases","volume":"20","author":"Murdaca","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.jneuroim.2023.578205_bb0105","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.4049\/jimmunol.1601725","article-title":"Aiolos overexpression in systemic lupus erythematosus B cell subtypes and BAFF-induced memory B cell differentiation are reduced by CC-220 modulation of Cereblon activity","volume":"199","author":"Nakayama","year":"2017","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.jneuroim.2023.578205_bb0110","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cyto.2014.09.007","article-title":"IL-22, cell regeneration and autoimmunity","volume":"74","author":"Nikoopour","year":"2015","journal-title":"Cytokine."},{"key":"10.1016\/j.jneuroim.2023.578205_bb0115","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1146\/annurev-immunol-031210-101312","article-title":"Regulation and functions of the IL-10 family of cytokines in inflammation and disease","volume":"29","author":"Ouyang","year":"2011","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jneuroim.2023.578205_bb0120","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.cyto.2017.07.022","article-title":"IL-33-matured dendritic cells promote Th17 cell responses via IL-1\u03b2 and IL-6","volume":"99","author":"Park","year":"2017","journal-title":"Cytokine."},{"issue":"9","key":"10.1016\/j.jneuroim.2023.578205_bb0125","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.4049\/jimmunol.2100565","article-title":"IL-10 as a Th2 cytokine: differences between mice and humans","volume":"207","author":"Rasquinha","year":"2021","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.jneuroim.2023.578205_bb0130","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1159\/000490855","article-title":"High frequency of Tc22 and Th22 cells in myasthenia gravis patients and their significant reduction after Thymectomy","volume":"25","author":"Robat-Jazi","year":"2018","journal-title":"Neuroimmunomodulation."},{"issue":"5","key":"10.1016\/j.jneuroim.2023.578205_bb0135","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.immuni.2005.09.015","article-title":"IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines","volume":"23","author":"Schmitz","year":"2005","journal-title":"Immunity."},{"issue":"12","key":"10.1016\/j.jneuroim.2023.578205_bb0140","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1016\/j.cellsig.2013.07.021","article-title":"IL-17 family cytokines mediated signaling in the pathogenesis of inflammatory diseases","volume":"25","author":"Song","year":"2013","journal-title":"Cell. Signal."},{"issue":"2","key":"10.1016\/j.jneuroim.2023.578205_bb0145","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.clim.2014.02.012","article-title":"Preferential production of IgG1, IL-4 and IL-10 in MuSK-immunized mice","volume":"151","author":"Ulusoy","year":"2014","journal-title":"Clin. Immunol."},{"issue":"3","key":"10.1016\/j.jneuroim.2023.578205_bb0150","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/cei.13546","article-title":"Roles of cytokines and T cells in the pathogenesis of myasthenia gravis","volume":"203","author":"Uzawa","year":"2021","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jneuroim.2023.578205_bb0155","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3389\/fimmu.2014.00520","article-title":"IgG subclasses and allotypes: from structure to effector functions","volume":"5","author":"Vidarsson","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jneuroim.2023.578205_bb0160","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jocn.2019.02.012","article-title":"Elevated expression of interleukin-33 in myasthenia gravis patients","volume":"63","author":"Wang","year":"2019","journal-title":"J. Clin. Neurosci."},{"issue":"7","key":"10.1016\/j.jneuroim.2023.578205_bb0165","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1212\/WNL.52.7.1487","article-title":"Myasthenia gravis activities of daily living profile","volume":"52","author":"Wolfe","year":"1999","journal-title":"Neurology."},{"issue":"50","key":"10.1016\/j.jneuroim.2023.578205_bb0170","doi-asserted-by":"crossref","first-page":"36083","DOI":"10.1074\/jbc.M113.506220","article-title":"CD154 is released from T-cells by a disintegrin and metalloproteinase domain-containing protein 10 (ADAM10) and ADAM17 in a CD40 protein-dependent manner","volume":"288","author":"Yacoub","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jneuroim.2023.578205_bb0175","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jaut.2013.12.005","article-title":"Characterization of CD4 and CD8 T cell responses in MuSK myasthenia gravis","volume":"52","author":"Yi","year":"2014","journal-title":"J. Autoimmun."},{"issue":"4","key":"10.1016\/j.jneuroim.2023.578205_bb0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0123546","article-title":"Differential cytokine changes in patients with myasthenia gravis with antibodies against AChR and MuSK","volume":"10","author":"Yilmaz","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jneuroim.2023.578205_bib186","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/cns.12774","article-title":"Th2 axis-related cytokines in patients with neuromyelitis optica spectrum disorders","volume":"24","author":"Zhang","year":"2018","journal-title":"CNS. Neurosci. Ther."},{"issue":"1","key":"10.1016\/j.jneuroim.2023.578205_bb0185","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/sji.12057","article-title":"Expression of interleukin-22 in myasthenia gravis","volume":"78","author":"Zheng","year":"2013","journal-title":"Scand. J. Immunol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572823001911?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572823001911?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:42:35Z","timestamp":1759048955000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572823001911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":39,"alternative-id":["S0165572823001911"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2023.578205","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum cytokine profiles in myasthenia gravis with anti-muscle-specific kinase antibodies","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2023.578205","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"578205"}}